178,461 Shares in Teladoc Health, Inc. (NYSE:TDOC) Acquired by Moore Capital Management LP

Moore Capital Management LP bought a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 178,461 shares of the health services provider's stock, valued at approximately $1,622,000. Moore Capital Management LP owned about 0.10% of Teladoc Health as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Whipplewood Advisors LLC purchased a new stake in Teladoc Health during the fourth quarter valued at about $29,000. Lindbrook Capital LLC boosted its position in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after buying an additional 1,612 shares during the period. Sterling Capital Management LLC boosted its position in Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after buying an additional 4,101 shares during the period. Pilgrim Partners Asia Pte Ltd purchased a new stake in Teladoc Health during the fourth quarter valued at about $60,000. Finally, Generali Investments Management Co LLC purchased a new stake in Teladoc Health during the fourth quarter valued at about $64,000. Institutional investors own 76.82% of the company's stock.

Insider Activity at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now owns 64,308 shares in the company, valued at approximately $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.58% of the stock is owned by insiders.

Teladoc Health Stock Up 3.8%

Shares of NYSE TDOC traded up $0.27 on Friday, reaching $7.52. 4,601,008 shares of the company's stock traded hands, compared to its average volume of 6,252,450. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The business's 50 day simple moving average is $7.58 and its two-hundred day simple moving average is $9.37. The company has a market cap of $1.32 billion, a price-to-earnings ratio of -1.30 and a beta of 1.82. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, equities research analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Piper Sandler cut their price target on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. The Goldman Sachs Group cut their price target on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Stifel Nicolaus dropped their target price on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Finally, Canaccord Genuity Group dropped their target price on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Twelve equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $9.71.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.